-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
4 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$439,579
Voyager Therapeutics, Inc. Insider Transactions
Voyager Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Swartz Robin
COO |
Sell | 1,357 @ $9.88 | $13,407 | 117,004 | 04/02/2024 | 04/03/2024 | |
|
Sandrock Alfred
CEO |
Sell | 12,115 @ $9.86 | $119,454 | 322,839 | 04/02/2024 | 04/03/2024 | |
|
Swartz Robin
COO |
Sell | 3,966 @ $7.45 | $29,547 | 118,361 | 02/21/2024 | 02/22/2024 | |
|
Sandrock Alfred
CEO |
Sell | 13,033 @ $7.46 | $97,226 | 334,954 | 02/21/2024 | 02/22/2024 | |
| Sell | 3,764 @ $7.46 | $28,079 | 175,669 | 02/21/2024 | 02/22/2024 | ||
|
Carter Todd Alfred
Chief Scientific Officer |
Sell | 3,365 @ $7.47 | $25,137 | 87,627 | 02/21/2024 | 02/22/2024 | |
|
Carter Todd Alfred
Chief Scientific Officer |
Sell | 602 @ $7.68 | $4,623 | 90,992 | 02/20/2024 | 02/22/2024 | |
|
Swartz Robin
COO |
Sell | 2,543 @ $7.15 | $18,182 | 72,327 | 01/17/2024 | 01/19/2024 | |
|
Carter Todd Alfred
Chief Scientific Officer |
Sell | 1,266 @ $7.18 | $9,090 | 53,094 | 01/17/2024 | 01/19/2024 | |
| Sell | 13,567 @ $6.99 | $94,833 | 149,433 | 10/03/2023 | 10/05/2023 | ||
|
Carter Todd Alfred
Chief Scientific Officer |
Sell | 10,500 @ $8.16 | $85,680 | 54,360 | 09/15/2023 | 09/18/2023 | |
|
Carter Todd Alfred
Chief Scientific Officer |
Sell | 5,500 @ $10.80 | $59,400 | 59,860 | 07/06/2023 | 07/10/2023 | |
|
Carter Todd Alfred
Chief Scientific Officer |
Sell | 5,000 @ $11.41 | $57,050 | 65,360 | 06/30/2023 | 07/05/2023 | |
|
Sandrock Alfred
CEO |
Sell | 7,437 @ $7.83 | $58,232 | 214,618 | 04/03/2023 | 04/05/2023 | |
|
Swartz Robin
COO |
Sell | 1,259 @ $7.83 | $9,858 | 71,617 | 04/03/2023 | 04/05/2023 | |
|
Swartz Robin
COO |
Sell | 15,373 @ $8.20 | $126,059 | 76,530 | 03/15/2023 | 03/17/2023 | |
|
NEUROCRINE BIOSCIENCES INC
10 percent owner |
Buy | 4,395,588 @ $8.88 | $39.03 M | 8,575,316 | 02/23/2023 | 02/24/2023 | |
|
Hesslein Robert W.
Senior VP & General Counsel |
Sell | 3,297 @ $7.45 | $24,563 | 106,610 | 02/17/2023 | 02/22/2023 | |
|
Carter Todd Alfred
Chief Scientific Officer |
Sell | 738 @ $7.45 | $5,498 | 67,553 | 02/17/2023 | 02/22/2023 | |
|
Carter Todd Alfred
Chief Scientific Officer |
Sell | 797 @ $7.67 | $6,113 | 34,291 | 02/13/2023 | 02/15/2023 |
Voyager Therapeutics, Inc. Frequently Asked Questions
-
Who is on Voyager Therapeutics, Inc.'s Insider Roster?
The list of insiders at Voyager Therapeutics, Inc. includes PFREUNDSCHUH PETER P., Carter Todd Alfred, Swartz Robin, Sandrock Alfred.
-
How much insider selling is happening at Voyager Therapeutics, Inc.?
Insiders have sold a total of 55,578 Voyager Therapeutics, Inc. shares in the last 12 months for a total of 439,579 sold.
-
Which Voyager Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Voyager Therapeutics, Inc. shares in the last 12 months: PFREUNDSCHUH PETER P. ($122,913), Carter Todd Alfred ($38,850), Swartz Robin ($61,136), Sandrock Alfred ($216,680),